Virax Biolabs Group Ltd
VRAX
$0.785+0.01 (+1.36%)
Aug 18, 2025, 3:20 PM
Financials
| 52Week High | 9.00 | 52Week Low | 0.72 |
| Beta | 1.75 | Current Ratio Annual | 7.27 |
| Current Ratio Quarterly | 7.27 | Gross Margin TTM | -838.39 |
| Market Cap | 3.21M | Net Profit Margin TTM | -95,754.34 |
| Operating Margin TTM | -97,360.03 | Price To Book | 0.56 |
| Price To Sales TTM | 507.66 | Quick Ratio Annual | 6.33 |
| Quick Ratio Quarterly | 6.33 | Return On Assets TTM | -76.39 |
| Return On Equity TTM | -84.53 | Return On Investment TTM | -79.12 |
| Revenue Growth5Y | -42.42 | Revenue Growth Quarterly Yoy | -98.27 |
| Revenue Growth TTMYoy | -95.95 | Revenue Per Share TTM | 0.00 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 8 | 1 | 1 | 0 | 0 | 0 | 63.01K | $141.37K |
| Mar 31, 2025 | 5(-38%) | 3(+200%) | 3(+200%) | 0 | 1(+%) | 0 | 63.10K(+0%) | $56.55K(-60%) |
| Jun 30, 2025 | 3(-40%) | 1(-67%) | 3 | 1(+%) | 0(-100%) | 0 | 35.16K(-44%) | $28.62K(-49%) |